291 related articles for article (PubMed ID: 11077444)
1. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins.
Glaunsinger BA; Lee SS; Thomas M; Banks L; Javier R
Oncogene; 2000 Nov; 19(46):5270-80. PubMed ID: 11077444
[TBL] [Abstract][Full Text] [Related]
2. Link of the unique oncogenic properties of adenovirus type 9 E4-ORF1 to a select interaction with the candidate tumor suppressor protein ZO-2.
Glaunsinger BA; Weiss RS; Lee SS; Javier R
EMBO J; 2001 Oct; 20(20):5578-86. PubMed ID: 11598001
[TBL] [Abstract][Full Text] [Related]
3. Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins.
Lee SS; Glaunsinger B; Mantovani F; Banks L; Javier RT
J Virol; 2000 Oct; 74(20):9680-93. PubMed ID: 11000240
[TBL] [Abstract][Full Text] [Related]
4. HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation.
Thomas M; Glaunsinger B; Pim D; Javier R; Banks L
Oncogene; 2001 Sep; 20(39):5431-9. PubMed ID: 11571640
[TBL] [Abstract][Full Text] [Related]
5. Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins.
Pim D; Thomas M; Banks L
Oncogene; 2002 Nov; 21(53):8140-8. PubMed ID: 12444549
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation.
Thomas M; Laura R; Hepner K; Guccione E; Sawyers C; Lasky L; Banks L
Oncogene; 2002 Aug; 21(33):5088-96. PubMed ID: 12140759
[TBL] [Abstract][Full Text] [Related]
7. Restoration of MAGI-1 expression in human papillomavirus-positive tumor cells induces cell growth arrest and apoptosis.
Kranjec C; Massimi P; Banks L
J Virol; 2014 Jul; 88(13):7155-69. PubMed ID: 24696483
[TBL] [Abstract][Full Text] [Related]
8. Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells.
Latorre IJ; Roh MH; Frese KK; Weiss RS; Margolis B; Javier RT
J Cell Sci; 2005 Sep; 118(Pt 18):4283-93. PubMed ID: 16141229
[TBL] [Abstract][Full Text] [Related]
9. Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein.
Zhang Y; Dasgupta J; Ma RZ; Banks L; Thomas M; Chen XS
J Virol; 2007 Apr; 81(7):3618-26. PubMed ID: 17267502
[TBL] [Abstract][Full Text] [Related]
10. Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein.
Frese KK; Lee SS; Thomas DL; Latorre IJ; Weiss RS; Glaunsinger BA; Javier RT
Oncogene; 2003 Feb; 22(5):710-21. PubMed ID: 12569363
[TBL] [Abstract][Full Text] [Related]
11. A new crucial protein interaction element that targets the adenovirus E4-ORF1 oncoprotein to membrane vesicles.
Chung SH; Frese KK; Weiss RS; Prasad BV; Javier RT
J Virol; 2007 May; 81(9):4787-97. PubMed ID: 17314165
[TBL] [Abstract][Full Text] [Related]
12. Surface plasmon resonance analysis of the binding of high-risk mucosal HPV E6 oncoproteins to the PDZ1 domain of the tight junction protein MAGI-1.
Fournane S; Charbonnier S; Chapelle A; Kieffer B; Orfanoudakis G; Travé G; Masson M; Nominé Y
J Mol Recognit; 2011; 24(4):511-23. PubMed ID: 20842623
[TBL] [Abstract][Full Text] [Related]
13. A Drosophila Model of HPV E6-Induced Malignancy Reveals Essential Roles for Magi and the Insulin Receptor.
Padash Barmchi M; Gilbert M; Thomas M; Banks L; Zhang B; Auld VJ
PLoS Pathog; 2016 Aug; 12(8):e1005789. PubMed ID: 27537218
[TBL] [Abstract][Full Text] [Related]
14. A systematic analysis of human papillomavirus (HPV) E6 PDZ substrates identifies MAGI-1 as a major target of HPV type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions.
Kranjec C; Banks L
J Virol; 2011 Feb; 85(4):1757-64. PubMed ID: 21123374
[TBL] [Abstract][Full Text] [Related]
15. Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein.
Lee SS; Weiss RS; Javier RT
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6670-5. PubMed ID: 9192623
[TBL] [Abstract][Full Text] [Related]
16. HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation.
Massimi P; Gammoh N; Thomas M; Banks L
Oncogene; 2004 Oct; 23(49):8033-9. PubMed ID: 15378012
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus E4-ORF1 Dysregulates Epidermal Growth Factor and Insulin/Insulin-Like Growth Factor Receptors To Mediate Constitutive Myc Expression.
Kong K; Kumar M; Taruishi M; Javier RT
J Virol; 2015 Nov; 89(21):10774-85. PubMed ID: 26269183
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand.
Ramirez J; Poirson J; Foltz C; Chebaro Y; Schrapp M; Meyer A; Bonetta A; Forster A; Jacob Y; Masson M; Deryckère F; Travé G
Angew Chem Int Ed Engl; 2015 Jun; 54(27):7958-62. PubMed ID: 26014966
[TBL] [Abstract][Full Text] [Related]
19. Cell polarity proteins: common targets for tumorigenic human viruses.
Javier RT
Oncogene; 2008 Nov; 27(55):7031-46. PubMed ID: 19029943
[TBL] [Abstract][Full Text] [Related]
20. A carboxy-terminal region required by the adenovirus type 9 E4 ORF1 oncoprotein for transformation mediates direct binding to cellular polypeptides.
Weiss RS; Javier RT
J Virol; 1997 Oct; 71(10):7873-80. PubMed ID: 9311876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
